Nevro Corp Company Leadership

NVRO Stock  USD 4.55  0.03  0.66%   
Nevro Corp's insiders are aggressively buying. The analysis of insiders' sentiment of trading Nevro Corp stock suggests that virtually all insiders are extremely bullish at this time. Nevro Corp employs about 1.2 K people. The company is managed by 33 executives with a total tenure of roughly 119 years, averaging almost 3.0 years of service per executive, having 36.82 employees per reported executive.
DKeith Grossman  Chairman
Chairman of the Board, President, Chief Executive Officer
Christopher Christoforou  President
Vice President - Research and Development

Nevro Corp's Insider Buying Vs Selling

100

 
Selling
 
Buying

Latest Trades

2023-06-07Shawn MccormickAcquired 7500 @ 22.88View
2022-05-09Kashif RashidAcquired 2250 @ 44.5View
2022-03-11Kashif RashidAcquired 1500 @ 64.04View
2022-03-08D Keith GrossmanAcquired 3200 @ 63.59View
2021-12-14Kevin C OboyleAcquired 2400 @ 83.78View
Monitoring Nevro Corp's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

Nevro Corp's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Nevro Corp's future performance. Based on our forecasts, it is anticipated that Nevro will maintain a workforce of about 1220 employees by December 2024.
 
Yuan Drop
 
Covid

Nevro Corp Management Team Effectiveness

The company has return on total asset (ROA) of (0.0902) % which means that it has lost $0.0902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2478) %, meaning that it created substantial loss on money invested by shareholders. Nevro Corp's management efficiency ratios could be used to measure how well Nevro Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to drop to -0.17. In addition to that, Return On Capital Employed is likely to drop to -0.19. At this time, Nevro Corp's Non Current Assets Total are very stable compared to the past year. As of the 26th of November 2024, Intangible Assets is likely to grow to about 33 M, while Total Assets are likely to drop about 461.8 M.
As of the 26th of November 2024, Net Income Applicable To Common Shares is likely to grow to about 2.8 M, while Common Stock Shares Outstanding is likely to drop about 26.7 M.

Nevro Corp Workforce Comparison

Nevro Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 26,686. Nevro Corp holds roughly 1,215 in number of employees claiming about 5% of equities under Health Care industry.

Nevro Corp Profit Margins

The company has Profit Margin (PM) of (0.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.530.6822
Significantly Down
Slightly volatile

Nevro Corp Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nevro Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nevro Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Nevro Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
0.3
3
10
 11,056 
 17,684 
2024-06-01
0.6111
11
18
 160,692 
 111,525 
2024-03-01
0.875
14
16
 441,330 
 29,266 
2023-12-01
0.5714
4
7
 3,648 
 12,006 
2023-09-01
1.0
5
5
 16,664 
 10,034 
2023-06-01
1.5455
17
11
 385,425 
 171,967 
2023-03-01
0.8
8
10
 133,767 
 29,280 
2022-12-01
1.6667
5
3
 12,691 
 3,081 
2022-09-01
4.0
4
1
 1,684 
 4,365 
2022-06-01
4.6667
14
3
 41,408 
 6,288 
2022-03-01
1.5
12
8
 266,240 
 141,594 
2021-12-01
4.5
9
2
 25,342 
 7,011 
2021-09-01
2.5
5
2
 9,997 
 9,240 
2021-06-01
1.6667
10
6
 8,547 
 18,096 
2021-03-01
0.7143
10
14
 49,002 
 17,387 
2020-12-01
0.5333
8
15
 4,578 
 36,939 
2020-09-01
0.24
6
25
 2,055 
 141,042 
2020-06-01
3.25
13
4
 54,399 
 8,791 
2020-03-01
0.7647
13
17
 82,593 
 140,694 
2019-12-01
0.35
7
20
 33,724 
 125,844 
2019-09-01
2.0
6
3
 107,932 
 7,276 
2019-06-01
6.5
13
2
 48,510 
 3,590 
2019-03-01
1.75
7
4
 242,498 
 15,955 
2018-12-01
1.6
8
5
 114,750 
 9,300 
2018-09-01
0.8
4
5
 28,300 
 29,164 
2018-06-01
1.8
9
5
 37,126 
 25,914 
2018-03-01
0.05
1
20
 7,000 
 217,019 
2017-12-01
1.7
17
10
 342,822 
 66,073 
2017-09-01
0.1515
5
33
 7,040 
 238,926 
2017-06-01
0.8571
18
21
 59,441 
 133,731 
2017-03-01
0.36
9
25
 217,839 
 161,600 
2016-12-01
0.6757
25
37
 287,034 
 349,028 
2016-09-01
0.0923
6
65
 12,000 
 442,500 
2016-06-01
0.3778
17
45
 72,207 
 258,780 
2016-03-01
0.3226
10
31
 438,408 
 141,987 
2015-12-01
0.5957
28
47
 292,422 
 329,453 
2015-09-01
0.125
1
8
 4,000 
 48,001 
2015-06-01
1.0
8
8
 67,445 
 2,387,403 
2014-12-01
1.1667
35
30
 13,908,967 
 11,115,709 
2014-06-01
1.0
1
1
 58,906 
 58,906 

Nevro Corp Notable Stakeholders

A Nevro Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nevro Corp often face trade-offs trying to please all of them. Nevro Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nevro Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kevin ThornalCEO PresidentProfile
DKeith GrossmanChairman of the Board, President, Chief Executive OfficerProfile
D GrossmanChairman of the Board, President, Chief Executive OfficerProfile
Christopher ChristoforouVice President - Research and DevelopmentProfile
Patrick SchmitzVice President - OperationsProfile
Roderick MacLeodChief Financial OfficerProfile
Elizabeth WeathermanIndependent DirectorProfile
Brad ValeIndependent DirectorProfile
Kevin OBoyleIndependent DirectorProfile
Shawn McCormickIndependent DirectorProfile
Frank FischerIndependent DirectorProfile
Michael DeManeLead Independent DirectorProfile
Susan SiegelIndependent DirectorProfile
Peter SocarrasGeneral VPProfile
Geeta KavetiVP OfficerProfile
Julie DeweyVice President - Investor Relations and Corporate CommunicationsProfile
Donald MiddlebrookVice President - Clinical, Regulatory and QualityProfile
Meredith VornholtVice MarketingProfile
Kashif JDSenior OfficerProfile
David CarawayChief Medical OfficerProfile
Christofer ChristoforouSenior OperationsProfile
Richard CarterChief OfficerProfile
Sridhar KosarajuDirectorProfile
Greg SillerSenior OfficerProfile
Shana MBASenior OfficerProfile
Michael CarterVice President - Global SalesProfile
Karen PrangeIndependent DirectorProfile
Angeline McCabeVice CommunicationsProfile
Kashif RashidChief Compliance Officer, General Counsel, Corporate SecretaryProfile
Niamh PellegriniChief Commercial OfficerProfile
Lori CianoChief Human Resource OfficerProfile
David MDSenior OfficerProfile
Jon ShearSenior DevelopmentProfile

About Nevro Corp Management Performance

The success or failure of an entity such as Nevro Corp often depends on how effective the management is. Nevro Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nevro management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nevro management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.16)(0.17)
Return On Capital Employed(0.18)(0.19)
Return On Assets(0.15)(0.15)
Return On Equity(0.31)(0.33)

Nevro Corp Workforce Analysis

Traditionally, organizations such as Nevro Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nevro Corp within its industry.

Nevro Corp Manpower Efficiency

Return on Nevro Corp Manpower

Revenue Per Employee349.9K
Revenue Per Executive12.9M
Net Loss Per Employee75.9K
Net Loss Per Executive2.8M
Working Capital Per Employee368.4K
Working Capital Per Executive13.6M
When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.87)
Revenue Per Share
11.404
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.09)
Return On Equity
(0.25)
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.